Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Tax Provisions (2018 - 2026)

Tandem Diabetes Care filings provide 8 years of Tax Provisions readings, the most recent being $5.2 million for Q4 2025.

  • On a quarterly basis, Tax Provisions rose 803.09% to $5.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.4 million, a 6.76% increase, with the full-year FY2025 number at $4.4 million, up 6.81% from a year prior.
  • Tax Provisions hit $5.2 million in Q4 2025 for Tandem Diabetes Care, up from -$4.0 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $8.5 million in Q1 2025 to a low of -$5.3 million in Q2 2025.
  • Median Tax Provisions over the past 5 years was $312000.0 (2021), compared with a mean of $648300.0.
  • The widest YoY moves for Tax Provisions: up 2901.85% in 2022, down 1373.5% in 2022.
  • Tandem Diabetes Care's Tax Provisions stood at $337000.0 in 2021, then tumbled by 176.56% to -$258000.0 in 2022, then tumbled by 420.54% to -$1.3 million in 2023, then surged by 44.53% to -$745000.0 in 2024, then surged by 803.09% to $5.2 million in 2025.
  • The last three reported values for Tax Provisions were $5.2 million (Q4 2025), -$4.0 million (Q3 2025), and -$5.3 million (Q2 2025) per Business Quant data.